Except for patient CC4C (MAP2K1 damaging variant), in whom some developmental delay features had already been observed, none of the CDD patients showed signs of the disorders attributed to the genes in which they had damaging de novo variants. The gene discussed is MAP2K1; the disease is craniodiaphyseal dysplasia.